1-4 of 4
Olga V. Lazareva
Close
Sort by
Journal Articles

The 15 Year Long-Term Survival of Patients with Chronic Myeloid Leukaemia from 35 Regions of Russian Federation: A Follow up of a Multicenter Observation Study Eutos Osp Initiated By European Leukemia NET

Olga V. Lazareva, Ekaterina Yu. Chelysheva, Olga Vinogradova, Anton Kulikovsky, Varvara I. Bakhtina, Eva Burnasheva, Tatiana Chagorova, Dolgorzhap Dasheeva, Elena Fedorova, Lubov Gavrilova, Nataliya Glonina, Anatoly Golenkov, Tatiana Klitochenko, Tatiana S. Konstantinova, Marina Kosinova, Marina Kozmina, Alexandr Korobkin, Galina Kuchma, Elza Lomaia, Alexander S. Luchinin, Anna Lyamkina, Ludmila Napso, Andrew Proidakov, Gysual Safuanova, Olga Senderova, Vasilisa Skatova, Anton Shutilev, Svetlana Volkova, Sergey Voloshin, Elena Volodicheva, Vera Yablokova, Andrew Zhuravkov, Andrey Zaritsky, Sergei M. Kulikov, Anna G. Turkina
Journal: Blood
Blood (2021) 138 (Supplement 1): 5035.
https://doi.org/10.1182/blood-2021-151371
Published: 2021
Journal Articles

On a Long Way to the Treatment Free Remisson: The Results of the Long-Term Observation of the Chronic Myeloid Leukemia Patients in Russian Part of EUTOS Population-Based Study

Olga V. Lazareva, PhD, Ekaterina Yu. Chelysheva, MD PhD, Anton Kulikovsky, Olga Senderova, Valentina Pepeliaeva, Sergey Meresiy, Alexander S. Luchinin, MD, Galina Milutina, Lubov Gavrilova, Ludmila Avdeeva, Dolgorzhap Dasheeva, Olga Vinogradova, MD PhD, Sergei M. Kulikov, PhD, Anna G. Turkina, Prof., MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5902.
https://doi.org/10.1182/blood-2019-131430
Published: 2019
Journal Articles

Challenge to Use the Interval Censorship Estimators for Time to Response Evaluation By Data from Chronic Myeloid Leukemia Registry

Sergey M. Kulikov, PhD, Irina A. Tischenko, Ekaterina Yu. Chelysheva, MD PhD, Olga V. Lazareva, PhD, Anna G. Turkina, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3140.
https://doi.org/10.1182/blood.V124.21.3140.3140
Published: 2014
Journal Articles

Treatment Cessation in Chronic Myeloid Leukemia As a Part of Treatment Process: Toxicity Determined and Active Stop of Tyrosine Kinase Inhibitors

Anna G. Turkina, MD PhD, Ekaterina Yu. Chelysheva, MD PhD, Vasiliy Shuvaev, Galina Gusarova, MD PhD, Anastasia Bykova, MD, Olga V. Lazareva, PhD, Oleg Shukhov, MD, Adham Abdullaev, MD PhD, Irina Martynkevich, Kudrat Abdulkadyrov, MD
Journal: Blood
Blood (2014) 124 (21): 5518.
https://doi.org/10.1182/blood.V124.21.5518.5518
Published: 2014